Search Results - "GHANNAM, A. F"
-
1
Oral montelukast compared with inhaled salmeterol To prevent exercise-induced bronchoconstriction: A randomized, double-blind trial
Published in Annals of internal medicine (18-01-2000)Get full text
Journal Article -
2
Activation parameters for the carbonic anhydrase II-catalyzed hydration of CO2
Published in The Journal of biological chemistry (25-01-1986)“…We have determined the activation parameters of kcat and kcat/Km for the carbonic anhydrase II-catalyzed hydration of CO2. The enthalpy and entropy of…”
Get full text
Journal Article -
3
Glycoprotein IIb/IIIa Receptor blockade improves outcomes in diabetic Patients presenting with Unstable angina/non-ST-elevation myocardial infarction: Results from the Platelet Receptor Inhibition in Ischemic syndrome management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study
Published in Circulation (New York, N.Y.) (14-11-2000)“…Diabetic patients who present with unstable angina or non-ST-elevation myocardial infarction suffer a substantially greater incidence of subsequent infarction…”
Get full text
Journal Article -
4
Furanone synthesis via an electrophilic capped carbonyl ylide
Published in Journal of the American Chemical Society (01-09-1990)Get full text
Journal Article -
5
Effects of montelukast and beclomethasone on airway function and asthma control
Published in Journal of allergy and clinical immunology (01-12-2002)“…Background: Maintaining asthma control is a major objective of therapy. Traditionally, the effectiveness of asthma therapy has been judged primarily by its…”
Get full text
Journal Article -
6
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge
Published in Respiratory medicine (01-11-2004)“…Objectives: To compare the effects of addition of montelukast or salmeterol to inhaled corticosteroids (ICS) on the response to rescue beta2-agonist use after…”
Get full text
Journal Article -
7
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group
Published in Annals of internal medicine (18-01-2000)“…Montelukast, an oral, once-daily leukotriene receptor antagonist, provides protection against exercise-induced bronchoconstriction. To evaluate the effect of 8…”
Get full text
Journal Article